Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study |
Nov 2024 |
Leukemia Research |
Myelodysplastic Syndromes (MDS) |
Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes |
Nov 2024 |
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study |
Nov 2024 |
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
Consensus recommendations for severe aplastic anemia |
Nov 2024 |
Blood Advances |
Aplastic Anemia |
Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment |
Nov 2024 |
International Journal of Molecular Sciences |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Safety and efficacy of danicopan in patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis |
Oct 2024 |
Expert Review of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology |
Oct 2024 |
Histopathology |
Myelodysplastic Syndromes (MDS) |
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes |
Oct 2024 |
Lancet Haematology |
Myelodysplastic Syndromes (MDS) |
Treatment of lower-risk myelodysplastic syndromes |
Oct 2024 |
Haematologica |
Myelodysplastic Syndromes (MDS) |
Detection of PNH Clones can Aid in the Distinction of Aplastic Anemia vs Inherited BM Failure Syndromes: A Single Center Experience and Review of the Literature |
Oct 2024 |
Clinical Lymphoma, Myeloma & Leukemia |
Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH) |